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The ASPIRE study: A midwifery-led research response to COVID-19 and beyond  
Carol Kingdon, Nicola Crossland, Claire Feeley, Marie-Clare Balaam, Deborah Powney, 




The health and social care research landscape is changing. In June 2021, the National 
Institute for Health Research (NIHR) published Best Research for Health: The next Chapter.1 
In the coming years the NIHR is seeking to become much more integrated across disciplines 
to better serve holistic research questions of the kind midwives may ask or contribute to. 
Earlier this year, Professor Jane Sandall was appointed as the first-ever Head of Midwifery 
Research at National Health Service (NHS) England. She will design and lead the midwifery 
research strategy for NHS England and Improvement on behalf of the Chief Midwifery 
Officer for England. Clinical Research Networks (CRNs) are an established part of the NIHR 
infrastructure. They help to deliver high quality research across England. These CRNs are 
also now active in strategic health partnerships that value midwives as critical to effective 
health and social care research. Launched in May 2021, the North West England Nursing, 
Midwifery & Allied Health Professionals (NMAHP) Research Capacity & Capability Strategy 
2021-242 provides a regional roadmap to promote and support Nursing, Midwifery and Allied 
Health Professional Research. ASPIRE provides a thread to begin to weave these 
developments together and consider the potential of midwifery research’s contribution to the 
next chapter. Best Research for Health demands that we build on the learnings from the 
research response to COVID-19. Studies funded or supported by the NIHR in partnership 
with the NHS have put the United Kingdom (UK) at the forefront of international efforts to find 
new ways to diagnose, treat and prevent the spread of COVID-19. These studies include 
trials of vaccine efficacy that midwives have recruited to and/or participated in. 3 Other 
studies have investigated the operation of the NHS during the pandemic, with the knowledge 
these studies generate seeking to restore service, and design and deliver them in a way that 
builds future resilience. ASPIRE is one of these studies.  
 
Summary  
This is the first article in a series reflecting on the role of research midwives in the ASPIRE study 
(Achieving Safe and Personalised maternity care In Response to Epidemics). In this article we 
introduce ASPIRE and provide an overview of the study. We also reflect on what makes ASPIRE 
uniquely midwifery-led within the National Institute for Health Research (NIHR) portfolio and the role of 
research midwives within recruitment sites. We hope this article, and those that follow in the series, 
written by ASPIRE research midwives, will serve as a roadmap to inspire the next chapter of 




Overview of the ASPIRE-COVID-19 study   
UK policy is for safe, personalised maternity care.4 However, during COVID-19 face to face 
provision of antenatal and postnatal tests and visits have been reduced in some places, and 
some women with worrying symptoms are not going to hospital. Many organisations are 
trying new solutions, including remote access technologies. Some Trusts have reduced 
community maternity services, including home and birth centre births; barred birth 
companions from accompanying their partners during ultrasound scans and in early labour; 
and reduced or stopped visiting to postnatal and neonatal wards. There have been media 
reports of women giving birth at home without professional help, either because midwives 
are unavailable, or for fear of being infected with COVID19 if they go to hospital. Other 
Trusts have been able to keep all or most of their services going and have rapidly developed 
innovative solutions to the issues raised by the pandemic. Reports from various professional 
and policy organisations suggest that these issues have had an effect on service users, their 
families, and maternity care staff. 
 
In contrast to increased centralisation of maternity care in the UK, some parts of the 
Netherlands have focused on maintaining community maternity services during COVID-19 
as far as possible. Building on experiences in the UK and the Netherlands, ASPIRE aims to 
find out how best to provide care for mothers, babies, and partners during and after a 
pandemic. We will look at what documents and national leads say about service organisation 
in both countries, and at women’s experiences. We will also look in detail at eight NHS 
Trusts. We will find out how their services have been organised during COVID-19, the 
experiences and feelings of parents and staff, and what the outcomes have been, including 
infections. Throughout the study, we will work with key stakeholders. Finally, we will agree 
on an organisational model that can be used across the UK to ensure safe, personalised 
routine maternity and neonatal care, both during pandemics and other similar crises, and for 
routine care into the future.  
 
ASPIRE is funded by the Economic and Social Research Council (ESRC), as part of the UK 
Research and Innovation’s (UKRI) rapid response to COVID-19.  Funding was awarded in 
June 2020 for 18 months. As shown in Box 1, the ASPIRE study has five distinct Work-
Packages. The principal focus of this article is Work Package 3, which is using an 
organisational case-study design to investigate the pandemic response in eight NHS Trusts 
providing maternity and neonatal services in England. This component of ASPIRE is known 





Work package 3: ASPIRE-COVID-19-CENTRE   
ASPIRE-COVID-19-CENTRE aims to describe the processes, outcomes, and staff and 
service user experiences of varying responses to the COVID-19 pandemic in NHS Trusts 
selected for maximum variation. In other words, we wanted sites that were different. Different 
in terms of population served, location and response to the pandemic. A ‘site’ comprised all 
the maternity services provided by a selected Trust (including hospital, birth centre and 
home settings). We used three routes to identify which sites to approach: best practice 
reported by national stakeholders interviewed in Work Package 2; a systematic sampling 
matrix; and via CRNs. Maternity statistics for England5 were used to compare 130 Trusts 
and shortlist 26 based on personalisation (i.e. retained homebirth service), safety (stillbirths), 
quality (Care Quality Commission rating), COVID-19 infection level, and local community 
factors (area level deprivation, child poverty and ethnicity).6 Box 2 provides an overview of 
Box 1: Overview of ASPIRE-COVID-19 study    
 
ASPIRE-COVID-19 comprises five overlapping work packages (WP) as outlined below. For 
further information please see the study website https://aspire-covid19.com/  
 
Work Package 1 (months 1-18): Project Governance 
 
Work Package 2 (months 2-8): International comparison, UK/Netherlands 
I. Documentary review COVID-19 guidelines/advice/reports/ from governmental, 
professional and service user sources (internal, and staff and public facing). 
II. Women’s views/experiences of maternity care provision before, during, and after 
COVID-19 through the B3 survey. 
III. Interviews with leads in relevant national governmental, professional, and service 
user organisations (n≤ 40 – n≤20 in the UK and n≤20 in The Netherlands). 
 
Work Package 3 (months 3-12): National in-depth case studies of eight NHS Trusts in England. 
There are three components to the case-study design: 
I. Documentary analysis; websites, social media, policies, minutes 
II. Semi-structured Interviews: heads of service (n≤ 80 – 10 in each Trust), health professionals 
and service user representatives (n≤ 200 – 25 in each Trust), and service users (n≤ 160 – 20 in 
each Trust) 
III. Clinical data: routinely collected data, key maternal and neonatal outcomes 
 
Work Package 4 (months 11-16): Clinical data analysis and modelling 
I. Data modelling, using causal inference techniques and multi-level modelling to 
draw comparisons within and between case study sites (WP3 data). 
II. A two-day consensus event with key stakeholders to share insights from data 
collected, to assess and refine the model, and prototype a toolkit to inform crisis 
and routine organisation of maternity care 
III. Further development and beta testing of the toolkit with the stakeholder group, to 
include algorithms, videos, podcasts, hints and tips. 
 
Work Package 5 (months 15-18): Synthesis, tool kit development and testing, dissemination, 
implementation and project close.   
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the study design reproduced from the study protocol and provides more detail about the 
proposed data sources listed in Box 1 (documentary review, stakeholder interviews, routinely 
collected data). Using our case study approach, data from each site will be examined both 
individually and across sites to reveal patterns of organisational responses and determine 


























Research Governance  
Regulatory approvals for the study were rapid with ethics approval fast-tracked via the 
Integrated Research Application System (IRAS). This expedited process of research 
approval was a direct response to the pandemic by the Health Research Authority (HRA). 
The opportunity for expedited research delivery was enhanced by the support of local CRNs. 
The NIHR Portfolio of studies consists of 6,000 quality studies eligible for support from the 





invited Expressions of Interest from potential sites) and Reproductive Health and Childbirth 
Research champions (who provided key midwifery contacts within Trusts approached 
directly). There were financial benefits for Trusts, enhanced study credibility and portfolio 
adoption entitled it to an assessment to proceed at a time when most studies were paused 
indefinitely. Between March 2020 and March 2021, the NIHR’s priority focus was Urgent 
Public Health (UPH) COVID-19 studies with all other Portfolio studies categorised according 
to the RESTART Framework.8 ASPIRE-COVID-19 CENTRE received HRA and IRAS 
approval on the 23rd of October 2020.  
 
Listening to stakeholders  
Semi-structured interviews are a method of qualitative widely used in research in midwifery 
to elicit views and experiences of professionals, women, and childbearing people.7 For 
ASPIRE, we designed three interview schedules. Heads of Service interviewees include 
Chief Executives, Directors of Nursing and Midwifery, Obstetric and Neonatal Clinical 
Directors. In the health professionals and service user representative’s participant group, we 
sought interviewees working in a range of midwifery roles (newly qualified, specialist, 
community), alongside neonatal staff, obstetric staff, general practitioners, health visitors,  
and maternity voices partnership leads amongst others. In the service user’s participant 
group, up to 20 service users (women), or service user pairs (women and partners) are 
purposively sampled to take part in semi-structured interviews. Inclusion criteria for service 
users is that they have become parents with a first or subsequent baby during the COVID-19 
pandemic in England. We have not excluded women who experienced the death of their 
baby before, during or soon after birth. We are trying to ensure the views and experiences of 
women of different parity, ages, ethnicities, and COVID-19 status are included.  
 
Moving research forward remotely  
As a university-based research team we had to find new ways of working to deliver the study 
during the pandemic. All interviews must be conducted remotely rather than face-to-face. We 
knew the NHS was investing heavily in digital capabilities during the pandemic, including the 
use of Microsoft (MS) Teams for its collaboration functionality and security features. For 
these reasons we chose MS Teams as the platform by which to run the study. MS Teams 
enabled us to devise systems that were both regulatory compliant and could be scaled up as 
new recruitment (Trust) sites came on board. Using MS Teams we created a digital space 
for each site where documents could be stored, stakeholder interviews could be scheduled, 
conducted, digitally recorded and logged simultaneously by university and Trust-based 
research teams. Research Midwives were provided with university contractor accounts. By 
accessing TEAMS using their university account they had access to the secure University 
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Network. Localised information sheets, consent forms and interview schedules were saved 
in the TEAMS space. Consent and interview recordings appeared in the posts. As soon as 
they were downloaded recordings were removed from MS Teams In accordance with our 
ethics approval all participant data had to be stored within the secure MS Teams sites that 
sat within the University Network. We also used digital enablers to enhance recruitment to 
stakeholder interviews via Twitter and Facebook Groups.  
 
Widening participation in research  
We sought patient and public involvement in the design of our study adverts, information 
sheets, consent forms and interview questions for service users. The wording on the consent 
form was simplified in response to feedback to try and widen participation from all sectors of 
the community. Despite our best efforts one social media advert targeting women from black 
and brown communities was responded to by white women, adding insights to the 
multifactorial issues of underrepresentation of some communities in research. Learning from 
this, we advised later sites to purposefully seek out participants from ethnically diverse 
communities earlier on in the recruitment phase to ensure we met our commitments to 
inclusivity. Another unintended consequence of our sampling approach was that actual sites 
are a mixture of Trusts that are more established research centres and those that are not. 
While our approach to conducting the study was the same for each site, the incidence of 
COVID-19 cases was a bigger impediment to recruitment accruals than research experience 
in the organisation. Therefore, as a combined team (UCLan researchers and research 
midwives) we learned to pivot and adapt to the changing landscapes across the sites. Good 
and close communication with supportive processes meant we were able to successfully 
recruit, albeit on a different timescale than originally planned.  The recruitment trajectories 
for the first four sites are shown in Figure 1 with all sites taking six months to meet the 
recruitment targets In some sites managers took a personal interest in the success of 








Role of research midwives within recruitment sites  
 
ASPIRE-COVID-19-CENTRE is unusual in the NIHR Portfolio because it has a strong 
qualitative component and Research Midwives within Trusts undertake interviews. The 
ESRC grant included funding for a Research Midwife in each Trust to champion the project, 
recruit participants for interview and conduct interviews. Typically, these funds have been 
spent on a shared post with a team of part-time research midwives recruiting and/or 
conducting interviews. A maximum of 55 interviews per site were specified in the study 
protocol with 20 interviews conducted by the university-based team and the remainder by 
the Research Midwives in Trusts. Qualitative interview training was provided alongside 
practice sessions for conducting the interviews remotely. These sessions helped to foster 
productive working relationships between the Trust and university teams. Initial challenges 
with the technology were shared and communication was regular. The first site opened on 
the 17th of November 2020. The team there comprised of three Research Midwives, the 
most senior of whom was also the local principal investigator (PI). During December 
recruitment to the study gained momentum with the Research Midwives and interviewees 
championing the study within the organisation and on social media. Feedback from 
participants was incredibly positive with many suggesting it was cathartic, particularly for 
staff, to participate in interviews.    
 
What makes ASPIRE midwifery-led research?  
It is rare, but not unheard of for Research Midwives to be local PIs in NIHR Portfolio studies. 
In ASPIRE, the first four sites to open all had midwives as PIs. The grant holder and Chief 
Investigator, Professor Soo Downe, is also midwife. However, it is the midwifery philosophy 





Month 1 Month 2 Month 3 Month 4 Month 5 Month 6
Cumulative Recruitment By Month Since Site 
Opening
Site 1 Site 2 Site 3 Site 4
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was conceived from a background of international evidence of safe and personalised care 
that predates the COVID-19 pandemic. Much of that evidence comes from midwifery.9 This 
evidence has not changed. Nor has England’s national policy ambition for Better Births.10 
The optimum organisational solutions to ensuring protection from COVID-19 infection (for 
staff and service users) at the same time as attaining high quality, safe and personalised 
maternity care are unknown. The ASPIRE study seeks to contribute to this evidence gap 
using a midwifery lens that centres women. At the study outset we used NHS England’s 
March 2020 definition of safe and personalised care.11 The study findings will report best 
practice for maintaining what stakeholders perceived as key to delivering safe and 
personalised care in a pandemic. The formulation of ASPIRE’s research questions is what 
makes it quintessentially midwifery research.   
 
Co-creation and collaboration  
ASPIRE’s research questions were informed by service user organisation concerns early in 
the pandemic, when contrary to available evidence, in some Trusts choice of place of birth 
was suspended and labour companionship restricted. Representatives from these 
organisations sit on the ASPIRE Advisory Committee. They have been involved in the 
research design and conduct and will inform the dissemination and implementation of the 
study’s findings. Advisory Committee membership includes representatives from the Stillbirth 
and Neonatal Death Society (SANDS), the human rights organisation BIRTHRIGHTS, the 
Royal Colleges (RCM, RCOG) and the International Confederation of Midwives. 
Collaboration is as pivotal to research in midwifery as it is to midwifery in practice.    
 
  
The next chapter: Towards a roadmap for midwifery-led research in the NIHR Portfolio  
Research in midwifery has a rich history of collaborations with obstetricians and social 
scientists, like those we have in the ASPIRE team. Opportunities for midwives to pursue 
research have been available since the 1970’s and they gained momentum during the 
1980’s when research expertise was established in quantitative and qualitative methods.12,13 
Writing in 2000, Renfrew and Proctor acknowledged that while research in midwifery had 
come far in the preceding 20 years, it remained patchy and of inconsistent quality. This 
observation led them to make the following recommendation: We need to increase the 
numbers of midwives involved in generating knowledge, so that knowledge is appropriate to 
the needs of midwives, women and babies. This will require investment in research training 
and a career structure which enables midwives to develop in research, as well as stay in the 
clinical context (p.201).14 Since 2006 the NIHR has changed the landscape of research in 
the NHS and enabled more and more midwives to be involved in generating knowledge from 
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research by undertaking a variety of roles. Research Midwives may develop specialist 
expertise by involvement in recruitment to clinical trials of specific conditions or treatments; 
or they may develop research skills by undertaking a local PI role in midwifery-led research. 
There is also the NIHR 70@70 NMAHP Research Leaders Programme that is strengthening 
the research-led care environment. All Trusts are now encouraged to work closely with 
CRNs to ensure their workforce can fulfil its research potential. The North West England 
NMAHP Strategy2 includes a training pathway of the kind Renfrew and Proctor 
recommended. This pathway illustrates the opportunities for personal transformation by 





Concluding remarks: role of research midwives  
The COVID-19 pandemic led the NHS to suspend many routine clinical services and the 
NIHR to target support towards priority Urgent Public Health COVID-19 studies, which have 
generated evidence that has underpinned the government response to the pandemic. Work 
is now underway to support the recovery and increase the UK’s research base. These 
developments include the vision set out by the Department of Health and Social Care in the 
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national documents (the NHS Long Term Plan15: the future of UK clinical research delivery16, 
Best Research for Health1 , UK Policy Framework for Health and Social Care Research 
Framework17), regional and Trust strategies. These strategies come at the same time as the 
new midwifery research strategy for NHS England and Improvement. The NIHR is now 
focused on RECOVERY and restoration of a fully active portfolio of NIHR research.18 
Midwives have a vital role to play in this recovery as consumers, champions, investigators, 
and leaders of research. We hope that this article and those that follow in the series (written 
by ASPIRE research midwives) will contribute to inspiring the next chapter of midwifery 
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